Thai FDA approves use of Covovax and Spikevax vaccines in younger people

Thailand’s Food and Drug Administration (TFDA) has approved the extended use of India’s Covovax (Novavax formulation) to cover those aged 12 to 17, instead of 18 and older, and the extended use of Moderna’s Spikevax in children aged 6 to 11, instead of 12 and older, according to the TFDA Secretary-General Dr Paisarn Dunkum.

Dr, Paisarn said today (Wednesday) that for those aged 12-17, two doses of 0.5 ml each of Covovax vaccine will be administered three weeks apart, the same dosage and interval period as people who are older.

Keep up to date with all things Thailand - Join our daily ASEAN NOW Thailand Newsletter - Click to subscribe

In the case of Spikevax, two doses of 0.25 ml, which is half the dosage for adults, will be administered to children aged 6-11, with a 4-week interval between the first and second doses, said Dr. Paisarn.

Full Story: https://www.thaipbsworld.com/thai-fda-approves-use-of-covovax-and-spikevax-vaccines-in-younger-people/